Vita Therapeutics Closes $31 Million Series B Financing To Develop Cell Therapies For Neuromuscular Diseases And Cancers
Amount Raised
$31 Million
Round Type
Series B
BaltimoreBiotechnologyHealthcareDescription
Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therapies to treat muscular dystrophies and cancers, today announced the completion of a $31 million Series B financing. The fundraise was led by Cambrian BioPharma and new investor Solve FSHD. New investors included Riptide Ventures and Cedars Sinai, which participated alongside TEDCO and other existing investors. Proceeds from the financing will be used to advance Vita’s lead pre-clinical program VTA-100 for limb-girdle muscular dystrophy (LGMD2A) to the clinic
Quick answer
Vita Therapeutics, Inc. raised $31 Million in a Series B round, dated October 12, 2022. Vita Therapeutics, Inc. is based in Baltimore, Maryland, United States.
- How much did Vita Therapeutics, Inc. raise?
- Vita Therapeutics, Inc. raised $31 Million in a Series B round on October 12, 2022.
- What does Vita Therapeutics, Inc. do?
- Vita Therapeutics, a Cambrian Biopharma affiliate, is a cell engineering company harnessing the power of genetics to develop cellular therapies that follow a dual manufacturing strategy, first beginning autologously..
- Where is Vita Therapeutics, Inc. based and how big is it?
- Vita Therapeutics, Inc. is based in Baltimore, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Vita Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Citius Pharmaceuticals, Inc. raised $3.6M (Seed) on November 21, 2022.
- Venus Concept Inc. raised $6.7M on November 18, 2022.
- Streamex Corp. raised $1.5M (Seed) on November 18, 2022.
- SCA Health raised $18K (Pre-Seed) on November 18, 2022.
- Ingenia Therapeutics raised $7M on November 18, 2022.
Who to call at Vita Therapeutics, Inc., and when
A new round usually means Vita Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vita Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vita Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vita Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vita Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansVita Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.